Latest Insider Transactions at Aardvark Therapeutics, Inc. (AARD)
This section provides a real-time view of insider transactions for Aardvark Therapeutics, Inc. (AARD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aardvark Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aardvark Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2025
|
Decheng Capital Global Life Sciences Fund Iv, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,250,000
+28.46%
|
$20,000,000
$16.0 P/Share
|
|
Feb 14
2025
|
Decheng Capital Global Life Sciences Fund Iv, L.P. |
BUY
Conversion of derivative security
|
Indirect |
2,667,299
+50.0%
|
-
|
|
Feb 14
2025
|
Jeffrey Chi |
BUY
Conversion of derivative security
|
Indirect |
133,364
+50.0%
|
-
|
|
Feb 14
2025
|
Vickers Venture Fund Vi Pte LTD |
BUY
Conversion of derivative security
|
Indirect |
2,050,902
+33.39%
|
-
|
|
Feb 14
2025
|
Tien Li Lee Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
16,542
+1.09%
|
$264,672
$16.0 P/Share
|
|
Feb 14
2025
|
Tien Li Lee Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
41,303
+2.72%
|
-
|
|
Feb 14
2025
|
Nelson Sun Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+9.13%
|
$160,000
$16.0 P/Share
|
|
Feb 14
2025
|
Nelson Sun Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
7,001
+7.26%
|
-
|
|
Feb 14
2025
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
187,500
+15.95%
|
$3,000,000
$16.0 P/Share
|
|
Feb 14
2025
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
800,189
+50.0%
|
-
|